ksx announces launch of home test in australia, page-10

Im expecting cap raising of between $3m and $5m before they list in US midyear. selling definitely from longtermers who will get in cheaper before the push.

their tieups are likely to be big. check out director RossH's previous comapnies and contacts. US cash will flow into this mob at some stage. exResmed execs aboard too, and come the revenues you would think resmed is a natural predator .... can't understand why they wouldnt just take them out now and bank the technology as a bolt on.

should get interesting before end of july for oppies holders is my tip. four months will be a clsoe run thing